NOVABAY PHARMACEUTICALS INC (NBY)
US66987P4090 - Common Stock
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
NBY stock results show that NovaBay Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!
NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!
NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
Why Is UiPath (PATH) Stock Down 30% Today?
UiPath stock is falling on Thursday after investors in PATH learned of a CEO change and a weak outlook in its latest earnings report.
Why Is NovaBay Pharmaceuticals (NBY) Stock Down 39% Today?
NovaBay Pharmaceuticals stock is down on Thursday after the company announced a reverse split for shares of NBY happening today.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!